Literature DB >> 19521247

Causal model of insight and psychopathology based on the PANSS factors: 1-year cross-sectional and longitudinal revalidation.

Samuel Suk-Hyun Hwang1, Jae Seung Chang, Kyu Young Lee, Se Hyun Kim, Yong Min Ahn, Yong Sik Kim.   

Abstract

This study presents results of a 1-year follow-up investigation of the causal model of insight in schizophrenia using a subsample of acute patients starting or switching to amisulpride included in an earlier study. Our causal model of insight based on the Positive and Negative Syndrome Scale factors, with the positive, negative, and autistic preoccupation factors designated as the primary predictors, and the activation factor as a mediating variable of insight, was examined for fitness at the stabilized stage (8 week) and at the chronic stage (1 year) using the structural equation modeling method. Results showed that the intercorrelations among the factors and regression coefficients toward insight changed in their magnitudes, but the validity of our hypothesized model of insight was still confirmed for both the stages with nearly perfect goodness-of-fitness indices. The fitness of the model was also confirmed for the longitudinal changes in the scores of insight and psychopathology. An alternative model, which included the anxiety/depressive factor as a second mediating variable between insight and the positive and negative factors, was also found to be valid for both the stages. A post-hoc causal model with anxiety/depressive factor showed tentative evidence favoring anxiety/depressive variable predicting insight than the other way around.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521247     DOI: 10.1097/YIC.0b013e32832d6bca

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  4 in total

1.  A prospective study of the trajectories of clinical insight, affective symptoms, and cognitive ability in bipolar disorder.

Authors:  Colin A Depp; Alexandrea L Harmell; Gauri N Savla; Brent T Mausbach; Dilip V Jeste; Barton W Palmer
Journal:  J Affect Disord       Date:  2013-10-02       Impact factor: 4.839

2.  The "Insight Paradox" in Schizophrenia: Magnitude, Moderators and Mediators of the Association Between Insight and Depression.

Authors:  Martino Belvederi Murri; Mario Amore; Pietro Calcagno; Matteo Respino; Valentina Marozzi; Mattia Masotti; Michele Bugliani; Marco Innamorati; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  Schizophr Bull       Date:  2016-04-11       Impact factor: 9.306

3.  Effectiveness of Electroconvulsive Therapy Augmentation on Clozapine-Resistant Schizophrenia.

Authors:  Hye Sung Kim; Se Hyun Kim; Nam Young Lee; Tak Youn; Jeoung Hyuk Lee; Seunghyun Chung; Yong Sik Kim; In Won Chung
Journal:  Psychiatry Investig       Date:  2016-12-29       Impact factor: 2.505

4.  The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses.

Authors:  Mario Amore; Martino Belvederi Murri; Pietro Calcagno; Paola Rocca; Alessandro Rossi; Eugenio Aguglia; Antonello Bellomo; Giuseppe Blasi; Bernardo Carpiniello; Alessandro Cuomo; Liliana dell'Osso; Massimo di Giannantonio; Giulia Maria Giordano; Carlo Marchesi; Palmiero Monteleone; Cristiana Montemagni; Lucio Oldani; Maurizio Pompili; Rita Roncone; Rodolfo Rossi; Alberto Siracusano; Antonio Vita; Patrizia Zeppegno; Alessandro Corso; Costanza Arzani; Silvana Galderisi; Mario Maj
Journal:  Eur Psychiatry       Date:  2020-05-06       Impact factor: 5.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.